C. Marco Timmers

1.5k total citations
39 papers, 1.1k citations indexed

About

C. Marco Timmers is a scholar working on Molecular Biology, Organic Chemistry and Reproductive Medicine. According to data from OpenAlex, C. Marco Timmers has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Organic Chemistry and 11 papers in Reproductive Medicine. Recurrent topics in C. Marco Timmers's work include Carbohydrate Chemistry and Synthesis (14 papers), Hypothalamic control of reproductive hormones (10 papers) and Glycosylation and Glycoproteins Research (7 papers). C. Marco Timmers is often cited by papers focused on Carbohydrate Chemistry and Synthesis (14 papers), Hypothalamic control of reproductive hormones (10 papers) and Glycosylation and Glycoproteins Research (7 papers). C. Marco Timmers collaborates with scholars based in Netherlands, United States and Canada. C. Marco Timmers's co-authors include Jacques H. van Boom, Rob Hanssen, Gijsbert A. van der Marel, Ruud van de Lagemaat, Chris J. van Koppen, Kimberly M. Bonger, Nicole C.R. van Straten, Julia Oosterom, Herman S. Overkleeft and Sietse Mosselman and has published in prestigious journals such as Endocrinology, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

C. Marco Timmers

39 papers receiving 1.0k citations

Peers

Countries citing papers authored by C. Marco Timmers

Since Specialization

Citations

This map shows the geographic impact of C. Marco Timmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Marco Timmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Marco Timmers more than expected).

Fields of papers citing papers by C. Marco Timmers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Marco Timmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Marco Timmers. The network helps show where C. Marco Timmers may publish in the future.

Co-authorship network of co-authors of C. Marco Timmers

This figure shows the co-authorship network connecting the top 25 collaborators of C. Marco Timmers. A scholar is included among the top collaborators of C. Marco Timmers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Marco Timmers. C. Marco Timmers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist 2023 ·Bioorganic & Medicinal Chemistry ·Willem F. J. Karstens, (unknown), (unknown), (unknown), (unknown), (unknown), Tanja A.E. van Achterberg, (unknown), (unknown), (unknown), Ruud Ubink, (unknown), Aloys L.A. Sesink, Marion Blomenröhr, C. Marco Timmers	5
2	Fluorescent small-molecule agonists as follicle-stimulating hormone receptor imaging tools 2020 ·RSC Chemical Biology ·Sascha Hoogendoorn, Gijs H.M. van Puijvelde, Gijsbert A. van der Marel, Chris J. van Koppen, C. Marco Timmers, Herman S. Overkleeft	2
3	Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985 2015 ·Molecular Pharmaceutics ·Ronald C. Elgersma, Ruud G. E. Coumans, (unknown), Wiro M. P. B. Menge, John Joosten, Henri Spijker, Franciscus M. H. de Groot, Miranda M.C. van der Lee, Ruud Ubink, Diels J. van den Dobbelsteen, David Egging, Wim H.A. Dokter, Gijs Verheijden, Jacques Lemmens, C. Marco Timmers, Patrick H. Beusker	163
4	Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor 2013 ·Biochemical Pharmacology ·Chris J. van Koppen, P. M. Verbost, Ruud van de Lagemaat, (unknown), (unknown), Tanja A.E. van Achterberg, (unknown), (unknown), (unknown), Jesse W.Y. Wat, (unknown), (unknown), (unknown), Rob Hanssen, C. Marco Timmers	38
5	Contraception by induction of luteinized unruptured follicles with short-acting low molecular weight FSH receptor agonists in female animal models 2011 ·Reproduction ·Ruud van de Lagemaat, Chris J. van Koppen, Magda A. M. Krajnc-Franken, (unknown), (unknown), S.M. Mulders, C. Marco Timmers	19
6	Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid‐stimulating hormone receptor 2011 ·British Journal of Pharmacology ·Chris J. van Koppen, Marcel E. de Gooyer, (unknown), Ralf Plate, Paolo Conti, (unknown), (unknown), (unknown), Jesse W.Y. Wat, Rob J. W. Berg, J. Robert Lane, André M. M. Miltenburg, C. Marco Timmers	39
7	Oligoproline helices as structurally defined scaffolds for oligomeric G protein-coupled receptor ligands 2010 ·Organic & Biomolecular Chemistry ·Kimberly M. Bonger, (unknown), Gijsbert M. Grotenbreg, Chris J. van Koppen, C. Marco Timmers, Gijsbert A. van der Marel, Herman S. Overkleeft	22
8	Synthesis and Pharmacological Evaluation of Dimeric Follicle‐Stimulating Hormone Receptor Antagonists 2009 ·ChemMedChem ·Kimberly M. Bonger, Sascha Hoogendoorn, Chris J. van Koppen, C. Marco Timmers, Herman S. Overkleeft, Gijsbert A. van der Marel	16
9	Discovery of Selective Luteinizing Hormone Receptor Agonists Using the Bivalent Ligand Method 2009 ·ChemMedChem ·Kimberly M. Bonger, Richard J. B. H. N. van den Berg, (unknown), Laura H. Heitman, Chris J. van Koppen, C. Marco Timmers, Herman S. Overkleeft, Gijsbert A. van der Marel	10
10	A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor 2008 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Chris J. van Koppen, Guido J.R. Zaman, C. Marco Timmers, J. Kelder, Sietse Mosselman, Ruud van de Lagemaat, Martin J. Smit, Rob Hanssen	77
11	Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core 2008 ·Bioorganic & Medicinal Chemistry ·Kimberly M. Bonger, Richard J. B. H. N. van den Berg, (unknown), Laura H. Heitman, Adriaan P. IJzerman, Julia Oosterom, C. Marco Timmers, Herman S. Overkleeft, Gijsbert A. van der Marel	13
12	Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor 2008 ·Human Reproduction ·Ruud van de Lagemaat, C. Marco Timmers, J. Kelder, (unknown), Sietse Mosselman, Rob Hanssen	56
13	Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263–275) epitope: an MHC anchor variant peptide for immune modulation 2007 ·Arthritis Research & Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ebo Bos, (unknown), Gijs Verheijden, C. Marco Timmers, (unknown)	14
14	Synthesis and evaluation of homo-bivalent GnRHR ligands 2007 ·Bioorganic & Medicinal Chemistry ·Kimberly M. Bonger, Richard J. B. H. N. van den Berg, Laura H. Heitman, Adriaan P. IJzerman, Julia Oosterom, C. Marco Timmers, Herman S. Overkleeft, Gijsbert A. van der Marel	48
15	[3H]Org 43553, the First Low-Molecular-Weight Agonistic and Allosteric Radioligand for the Human Luteinizing Hormone Receptor 2007 ·Molecular Pharmacology ·Laura H. Heitman, Julia Oosterom, Kimberly M. Bonger, C. Marco Timmers, (unknown), Adriaan P. IJzerman	40
16	The β-glucuronyl-based prodrug strategy allows for its application on β-glucuronyl-platinum conjugates 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), C. Marco Timmers, Steven van Zutphen, Gijsbert A. van der Marel, Herman S. Overkleeft, Jacques H. van Boom, J. Reedijk	22
17	The First Orally Active Low Molecular Weight Agonists for the LH Receptor: Thienopyr(im)idines with Therapeutic Potential for Ovulation Induction 2002 ·ChemBioChem ·Nicole C.R. van Straten, (unknown), (unknown), (unknown), Anton E.P. Adang, C. Marco Timmers, Rob Hanssen, C. A. A. VAN BOECKEL	80
18	Synthesis of the antibiotically active part of agrocin 84 1998 ·Tetrahedron Letters ·Dmitri V. Filippov, C. Marco Timmers, (unknown), Gijs A. van der Marel, Jacques H. van Boom	8
19	ChemInform Abstract: Stereoselective Synthesis of α‐C‐(Alkynyl)‐glycosides via Ring‐ Opening of α‐1,2‐Anhydrosugars. 1997 ·ChemInform ·Michiel A. Leeuwenburgh, C. Marco Timmers, Gijsbert A. van der Marel, Jacques H. van Boom, Jean‐Maurice Mallet, Pierre Sînaÿ	2
20	An Alternative Route to the Preparation of (3′ → 5′) Methylene Acetal Linked Di- and Trinucleosides 1993 ·Synthesis ·Peter J. L. M. Quaedflieg, C. Marco Timmers, Gijs A. van der Marel, E. Kuyl‐Yeheskiely, Jacques H. van Boom	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact